Cinclus Pharma and Implantica, a duo of Swedish companies, are working to create new therapies for gastroesophageal reflux disease (GERD) but are approaching the problem from opposite ends of the health care spectrum.
Implantica has developed RefluxStop, a CE-marked implant designed to transform the anatomical features associated with GERD.